Christopher Johnson Email & Phone Number

Alameda, California, Us

South San Francisco, Ca, Us

• Responsible for building a new team of nine Key Account Specialists for the launch of the fist BiTE - Blinatumomab in Acute Lymphoblastic Leukemia in the inpatient, outpatient and home health care settings • Recruited and hired a team of tenured and highly successful oncology sales professionals for nine territories from the West Coast to the Midwest• Provide insight and feedback to senior leadership and the marketing team for launch readiness, brand planning and strategic vision

South San Francisco, Ca, Us

• Provide leadership and direction to a team of Senior Oncology Specialists to exceed our Nexavar (HCC, DTC, RCC) and Stivarga (CRC, GIST) sales objectives at the territory and regional level • Develop, implement and coordinate sales strategies for major accounts and academic centers throughout the region• Recruited a team of tenured and highly successful oncology sales professionals for five realigned territories• Routinely provide insight to cross functional teams including sales operations, marketing, and business analytics• Received Onyx Standard of Excellence-High for 2012 & 2013• Finished 2nd out of 7 regions in President’s Club rankings for 2013• Trained in the following Baron Group Leadership Development Courses: ‘Coaching for Improved Sales Performance’ and ‘Conducting Meetings Effectively by Applying Facilitation Skills’

South San Francisco, Ca, Us

-Responsible for the sales and promotion of Nexavar (Sorafenib) for unresectable hepatocellular carcinoma and advanced renal cell carcinoma -Manage sales activities at key accounts within territory including City of Hope, Loma Linda Medical Center, US Oncology, and VA Loma Linda and Las Vegas-In-service oncologists and nurses on the safe administration of Nexavar-Ranked #1 in President’s Club Rankings for 2010-Ranked #3 in President’s Club Rankings for 2011-Sprit of Onyx Award winner 2011-Winner of 2010 ESMO award trip for highest volume increase in 2H of 2009 versus 1H of 2009-Trained in the Baron Group Consultative Selling SkillsRegional Training Liaison – West - July 2011 to Present-Assisted Regional Manager in hiring of SOS for Los Angeles Territory-Facilitated Regional Meetings and conference calls for the West from a training perspective-Assisted Training Director with training of Los Angeles new hire in HCC and RCC-Trained in the Baron Group Coaching Skills May 2012

Nutley, Nj, Us

-Responsible for the sales and promotion of Eisai’s Cutaneous T-Cell Lymphoma products Ontak(denileukin diftitox) and Targretin(bexarotene)-Facilitate corporate communication with the Director of the CTCL Center at UCLA, Lauren Pinter-Brown, MD-Prospect community based oncologists for CTCL patients-In-service infusion centers on the safe administration of Ontak-Provide reimbursement assistance to both community and institution based practices-Completed PCI Management Development Course

Veenendaal, Utrecht, Nl

-Responsible for the sales and promotion of the brachytherapy product line including: HDR Brachytherapy Afterloaders, Cone Beam CT, Simulators, Treatment Planning Software, Devices and Applicators-Provide product demonstrations to Radiation Oncologists, -Physicists, Radiation Therapists, and Dosimetrists -Present Pro Forma Data to economic buyers to illustrate income structure and cost of ownership-Generate leads and develop quotations for prospective customers-Negotiate terms and conditions of capital and service contracts-Manage and prospect install base for new revenue streams

Emeryville, California, Us

-Manage Key Accounts at hospital based Interleukin (rIL-2) High Dose Centers for the treatment of Metastatic Renal Cell Carcinoma and Metastatic Melanoma-Facilitate training for physicians and nurses in ICU and Oncology Floor on the safe administration of High Dose IL-2, including dosing, toxicity management and pre and post therapy patient management-Provide reimbursement assistance to the billing and coding departments for proper documentation of IL-2 cases to maximize reimbursement-Promote High Dose IL-2 therapy to community oncologists and urologists, aid in patient identification, and provide referral assistance to High Dose IL-2 Treatment Centers-Manage corporate communication and relationships with Key Opinion Leaders at academic and research institutions including: Robert Figlin, MD of the UCLA Kidney Cancer Program/City of Hope, Steven O’Day, MD of The Angeles Clinic/John Wayne Cancer Institute, and David Quinn, MD of the USC/Norris Comprehensive Cancer Center

Boston, Massachusetts, Us

-Responsible for the promotion of recombinant gonadotrophins and reproductive health line to academic and community based IVF Centers, Reproductive Endocrinologists, Embryologist, and infertility nurses -Worked directly with Reproductive Endocrinologists, Practice CEO’s, and nurses to develop and implement strategies for practice expansion, patient education, staff education, and managed care initiatives

New York, New York, Us

• Responsible for the promotion of the women’s health line including the Premarin family of products and oral contraceptives, as well as the CNS line including Effexor XR and Sonata• Achieved top market share within district, area and zone for Premarin Family – 85% market share in 1999• Ranked # 1 in area out of 28 Ayerst Reps for 1999• Winner of Radnor Cup-1999 for top performance in Western Zone• Worked within managed care environment calling on providers for Medi-Cal, Care More, and Health Care Partners